Literature DB >> 3015905

Electron transfer across the chromaffin granule membrane. Use of EPR to demonstrate reduction of intravesicular ascorbate radical by the extravesicular mitochondrial NADH:ascorbate radical oxidoreductase.

L M Wakefield, A E Cass, G K Radda.   

Abstract

A two-compartment electron paramagnetic resonance system has been developed in which the membrane-impermeable spin probe Ni(en)2+3 is used to selectively eliminate the EPR signal from extravesicular ascorbate radical, such that radicals in intra- and extravesicular compartments can be distinguished. Using this system, we have shown that an increase in ascorbate radical in the extravesicular medium is reflected by an increase in ascorbate radical within resealed chromaffin granule ghosts containing trapped ascorbate but has no effect on radical concentrations inside liposomes containing ascorbate. This indicates that the chromaffin granule membrane contains a component, not present in liposomes, that allows equilibration between the intra- and extravesicular ascorbate/ascorbate radical couples. This component is probably cytochrome b561. We further show that activation of the mitochondrial NADH:ascorbate radical oxidoreductase in the extravesicular medium causes a decrease in intravesicular ascorbate radical in chromaffin granule ghosts but not in liposomes. These data provide direct experimental evidence for the hypothesis that the adrenal medullary mitochondrial NADH:ascorbate radical oxidoreductase could drive the re-reduction of ascorbate free radical generated inside the chromaffin granule by the turnover of dopamine beta-hydroxylase, without the ascorbate radical ever having to leave the granule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  The Role of Ascorbate Free Radical as an Electron Acceptor to Cytochrome b-Mediated Trans-Plasma Membrane Electron Transport in Higher Plants.

Authors:  N. Horemans; H. Asard; R. J. Caubergs
Journal:  Plant Physiol       Date:  1994-04       Impact factor: 8.340

2.  Human cytochrome b561: a revised hypothesis for conformation in membranes which reconciles sequence and functional information.

Authors:  M Srivastava; K R Gibson; H B Pollard; P J Fleming
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

Review 3.  Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.

Authors:  Fiona E Harrison; James M May
Journal:  Free Radic Biol Med       Date:  2009-01-06       Impact factor: 7.376

4.  Axial ligation and stoichiometry of heme centers in adrenal cytochrome b561.

Authors:  Yury Kamensky; Wen Liu; Ah-Lim Tsai; Richard J Kulmacz; Graham Palmer
Journal:  Biochemistry       Date:  2007-06-30       Impact factor: 3.162

5.  The structure of cytochrome b561, a secretory vesicle-specific electron transport protein.

Authors:  M S Perin; V A Fried; C A Slaughter; T C Südhof
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

Review 6.  Duodenal cytochrome b (DCYTB) in iron metabolism: an update on function and regulation.

Authors:  Darius J R Lane; Dong-Hun Bae; Angelica M Merlot; Sumit Sahni; Des R Richardson
Journal:  Nutrients       Date:  2015-03-31       Impact factor: 5.717

7.  The effects of meldonium on the acute ischemia/reperfusion liver injury in rats.

Authors:  Siniša Đurašević; Maja Stojković; Jelena Sopta; Slađan Pavlović; Slavica Borković-Mitić; Anđelija Ivanović; Nebojša Jasnić; Tomislav Tosti; Saša Đurović; Jelena Đorđević; Zoran Todorović
Journal:  Sci Rep       Date:  2021-01-14       Impact factor: 4.379

8.  A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immunologically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia.

Authors:  K Shirabe; M T Landi; M Takeshita; G Uziel; E Fedrizzi; N Borgese
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.